elgium). He received both his doctoral degree, in biochemistry, and Bachelor of Science degree, in biology, from Facultés Universitaires de la Paix (Namur, Belgium). Bille also was a visiting scientist at the Université Pierre and Marie Curie, Paris VII-Jussieu (Paris, France) in the biological organic chemistry laboratory. There, he worked under Andrée Marquet, Ph.D., in the group of renowned peptide chemist Solange Lavielle, Ph.D.
Tomi Sawyer, Ph.D.
Sawyer is chief scientific officer of Aileron Therapeutics (Cambridge, Mass.), a biopharmaceutical company that is developing stabled peptides, a new class of drugs. Previously, he served as senior director of the Pfizer Research Technology Center (Cambridge) and Pfizer's global chemistry leadership team. Sawyer also has held management and scientific positions in research and development at ARIAD Pharmaceuticals, Inc. (Cambridge), Parke-Davis/Warner-Lambert Company (Ann Arbor, Mich.), and The Upjohn Company (Kalamazoo, Mich.).
Sawyer is the recipient of the Vincent du Vigneaud Award for outstanding achievements in peptide research, the inventor of more than 60 issued or filed scientific patents, an author of more than 200 books, reviews, commentaries and research articles, and the founding editor-in-chief of Chemical Biology & Drug Design. He also is a former president of the American Peptide Society. Sawyer received a Bachelor of Science degree in chemistry, with honors, from Moorhead State University (now Minnesota State University in Moorhead, Minn.), and a doctoral degree in organic chemistry, with distinction, from the University of Arizona, working under Victor Hruby, Ph.D.
Ved Srivastava, PhD.
Srivastava is the associate director of discovery research for Amylin Pharmaceuticals, Inc. (San Diego), where he leads the peptide chemistry core team with a focus in discovery, synthesis and development of novel peptide hormones for diabetes, obesity and neuro
Page: 1 2 3 4 Related biology technology :1
Copyright©2008 Vocus, Inc.
All rights reserved
. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.2
. New England Peptide Names Director of Chemical Development3
. New England Peptide Implements Quality Management System, Prepares for ISO 9001: 2008 Registration4
. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability5
. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center6
. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:7
. Tandem Labs New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England8
. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.9
. Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure10
. Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology.11
. Nektars PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress